GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CHO Pharma 6586.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

76.40

+2.96%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 1.4m

FY2016FY2025

Net income

−TWD 290.0m

FY2016FY2025

Free cash flow

−TWD 291.3m

FY2016FY2025

Shareholders' equity

TWD 2.46bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 1.4mTWD 3.6m—TWD 60,000TWD 3.6mTWD 138,000TWD 297,000TWD 290,000TWD 396,000TWD 2.0m
Research and developmentTWD 286.9mTWD 219.1mTWD 239.4mTWD 326.1mTWD 193.5mTWD 287.9mTWD 344.6mTWD 284.2mTWD 275.9mTWD 230.5m
Operating income−TWD 325.8m−TWD 249.3m−TWD 306.0m−TWD 338.1m−TWD 205.3m−TWD 296.1m−TWD 369.2m−TWD 319.2m−TWD 323.7m−TWD 263.1m
Net income−TWD 290.0m−TWD 212.2m−TWD 306.1m−TWD 338.4m−TWD 205.9m−TWD 296.8m−TWD 358.4m−TWD 306.6m−TWD 309.2m−TWD 245.5m
Diluted earnings per share-1.36-1.00-1.54-1.84-0.97-1.40-1.68-1.69-1.71-1.36

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 2.57bnTWD 2.88bnTWD 3.09bnTWD 1.60bnTWD 1.89bnTWD 2.14bnTWD 2.43bnTWD 2.67bnTWD 2.93bnTWD 3.21bn
Cash and short-term investments——TWD 2.60bnTWD 1.04bnTWD 1.32bnTWD 1.53bnTWD 1.80bnTWD 2.08bnTWD 2.31bnTWD 2.56bn
Total liabilitiesTWD 109.1mTWD 132.6mTWD 110.8mTWD 173.7mTWD 149.7mTWD 179.7mTWD 29.0mTWD 62.6mTWD 31.8mTWD 36.2m
Debt———TWD 11.7mTWD 25.6mTWD 38.3mTWD 29.0m———
Shareholders' equityTWD 2.46bnTWD 2.75bnTWD 2.98bnTWD 1.43bnTWD 1.74bnTWD 1.96bnTWD 2.26bnTWD 2.61bnTWD 2.89bnTWD 3.18bn
Shares outstanding213m213m199m184m213m213m213m181m181m180m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 279.6m−TWD 217.4m−TWD 291.1m−TWD 249.5m−TWD 193.5m−TWD 248.7m−TWD 266.7m−TWD 244.7m−TWD 251.2m−TWD 168.9m
Capital spending−TWD 11.7m−TWD 5.5m−TWD 2.0m−TWD 9.4m−TWD 2.6m−TWD 22.2m−TWD 11.4m−TWD 2.8m−TWD 5.1m−TWD 13.1m
Free cash flow−TWD 291.3m−TWD 222.9m−TWD 293.1m−TWD 258.9m−TWD 196.1m−TWD 270.9m−TWD 278.2m−TWD 247.5m−TWD 256.3m−TWD 182.0m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023
RevenueTWD 712,000TWD 2.5mTWD 541,000TWD 541,000————
Operating income−TWD 136.7m−TWD 131.2m−TWD 59.0m−TWD 59.0m−TWD 56.9m−TWD 56.9m−TWD 77.6m−TWD 77.6m
Net income−TWD 118.1m−TWD 112.2m−TWD 50.0m−TWD 50.0m−TWD 77.6m−TWD 77.6m−TWD 75.4m−TWD 75.4m
Diluted earnings per share-0.55-0.52-0.24-0.24-0.39-0.39-0.38-0.38
Cash from operations−TWD 129.0m−TWD 115.0m−TWD 51.0m−TWD 51.0m−TWD 71.0m−TWD 71.0m−TWD 73.0m−TWD 73.0m
Capital spending−TWD 2.0m−TWD 1.0m−TWD 1.0m−TWD 1.0m————
Free cash flow−TWD 131.0m−TWD 116.0m−TWD 52.0m−TWD 52.0m————
Total assetsTWD 2.74bnTWD 2.88bnTWD 3.01bnTWD 3.01bnTWD 3.09bnTWD 3.09bnTWD 1.44bnTWD 1.44bn
Cash and short-term investments——TWD 2.49bnTWD 2.49bnTWD 2.60bnTWD 2.60bnTWD 892.4mTWD 892.4m
Debt——————TWD 5.9m—
Shareholders' equityTWD 2.63bnTWD 2.75bnTWD 2.88bnTWD 2.88bnTWD 2.98bnTWD 2.98bnTWD 1.28bnTWD 1.28bn

Financial ratios

Data as of 13 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-20237.6%-5909.1%—-563486.7%-5752.1%-214539.1%-124297.3%
Net margin-20266.0%-5928.1%—-563988.3%-5768.2%-215100.7%-120664.0%
Return on equity-11.8%-7.7%-10.3%-23.7%-11.8%-15.1%—
Return on assets-11.3%-7.4%-9.9%-21.1%-10.9%-13.9%—
Free cash flow yield—-0.9%-1.3%-1.2%———
Revenue growth-60.0%——-98.3%2487.0%-53.5%—
Earnings growth36.6%-30.7%-9.5%64.3%-30.6%-17.2%—
Current ratio19.47x20.81x24.93x6.39x10.06x10.37x—
Debt to equity———0.01x0.01x0.01x—
Equity ratio95.8%95.4%96.4%89.2%92.1%91.6%—
Interest coverage-713.30x-311.56x-3974.16x-1123.23x-356.51x-382.02x—
R&D as a share of sales20045.5%6119.5%—543495.0%5420.3%208610.1%116037.4%
Buybacks as a share of market value—-7.1%-8.0%————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue187.8%59.6%—
Operating income-1.2%1.9%8.7%
Net income-5.0%-0.5%10.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-11477.4%———
Net margin-10022.6%———

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-20.6-51.1-44.7-73.1-56.0-11.6-9.3-11.7-19.5

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.